Last reviewed · How we verify

Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study

NCT05574894 PHASE3 COMPLETED

This retrospective cohort study aims to investigate the effects of recombinant human growth hormone (rh-GH) on the euploid status of preimplantation blastocysts in AMA patients. Infertile patients aged 38-46 years old were recruited for study if they fulfill the inclusion criteria and do not have the exclusion criteria. Treatment group: Women received growth hormone (GH) supplement during antagonist protocol for ovarian stimulation. Control group: Women received antagonist protocol for ovarian stimulation. The primary outcome is the euploidy rate of blastocysts per stimulation cycle and per testing cycle.

Details

Lead sponsorShangHai Ji Ai Genetics & IVF Institute
PhasePHASE3
StatusCOMPLETED
Enrolment692
Start dateFri Jan 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionFri Sep 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

China